These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 1428723

  • 1. In vitro and in vivo circumvention of multidrug resistance by Servier 9788, a novel triazinoaminopiperidine derivative.
    Pierré A, Dunn TA, Kraus-Berthier L, Léonce S, Saint-Dizier D, Régnier G, Dhainaut A, Berlion M, Bizzari JP, Atassi G.
    Invest New Drugs; 1992 Aug; 10(3):137-48. PubMed ID: 1428723
    [Abstract] [Full Text] [Related]

  • 2. Effects of a new triazinoaminopiperidine derivative on adriamycin accumulation and retention in cells displaying P-glycoprotein-mediated multidrug resistance.
    Léonce S, Pierré A, Anstett M, Pérez V, Genton A, Bizzari JP, Atassi G.
    Biochem Pharmacol; 1992 Nov 03; 44(9):1707-15. PubMed ID: 1360210
    [Abstract] [Full Text] [Related]

  • 3. In vivo evidence of complete circumvention of vincristine resistance by a new triazinoaminopiperidine derivative S 9788 in P388/VCR leukemia model.
    Cros S, Guilbaud N, Berlion M, Dunn T, Regnier G, Dhainaut A, Atassi G, Bizzari JP.
    Cancer Chemother Pharmacol; 1992 Nov 03; 30(6):491-4. PubMed ID: 1394807
    [Abstract] [Full Text] [Related]

  • 4. Reversal of multidrug resistance by a novel quinoline derivative, MS-209.
    Sato W, Fukazawa N, Nakanishi O, Baba M, Suzuki T, Yano O, Naito M, Tsuruo T.
    Cancer Chemother Pharmacol; 1995 Nov 03; 35(4):271-7. PubMed ID: 7828268
    [Abstract] [Full Text] [Related]

  • 5. In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Guilbaud N, Kraus-Berthier L, Saint-Dizier D, Rouillon MH, Jan M, Burbridge M, Visalli M, Bisagni E, Pierré A, Atassi G.
    Cancer Chemother Pharmacol; 1996 Nov 03; 38(6):513-21. PubMed ID: 8823492
    [Abstract] [Full Text] [Related]

  • 6. [In vitro characterization of S9788, a new modulator of multidrug resistance].
    Pérez V, Pierré A, Léonce S, Anstett M, Prost JF, Atassi G.
    Bull Cancer; 1993 Apr 03; 80(4):310-25. PubMed ID: 8173185
    [Abstract] [Full Text] [Related]

  • 7. Circumvention of multidrug resistance by a newly synthesized quinoline derivative, MS-073.
    Sato W, Fukazawa N, Suzuki T, Yusa K, Tsuruo T.
    Cancer Res; 1991 May 01; 51(9):2420-4. PubMed ID: 1673087
    [Abstract] [Full Text] [Related]

  • 8. Identification of two distinct intracellular sites that contribute to the modulation of multidrug resistance in P388/ADR cells expressing P-glycoprotein.
    Mayer LD, Lim KT, Hartley D.
    J Exp Ther Oncol; 2002 May 01; 2(2):107-20. PubMed ID: 12415627
    [Abstract] [Full Text] [Related]

  • 9. Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers.
    Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1983 Jun 01; 43(6):2905-10. PubMed ID: 6850602
    [Abstract] [Full Text] [Related]

  • 10. Reversal of multidrug resistance by an immunosuppressive agent FK-506.
    Naito M, Oh-hara T, Yamazaki A, Danki T, Tsuruo T.
    Cancer Chemother Pharmacol; 1992 Jun 01; 29(3):195-200. PubMed ID: 1370765
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacological properties of S9788, a new modulator of multidrug resistance].
    Bull Cancer; 1994 Feb 01; 81(2):93-103. PubMed ID: 7894124
    [Abstract] [Full Text] [Related]

  • 12. Circumvention of multidrug resistance in P388 murine leukemia cells by a novel inhibitor of cyclic AMP-dependent protein kinase, H-87.
    Miyamoto K, Wakusawa S, Nakamura S, Koshiura R, Otsuka K, Naito K, Hagiwara M, Hidaka H.
    Cancer Lett; 1990 May 15; 51(1):37-42. PubMed ID: 2337896
    [Abstract] [Full Text] [Related]

  • 13. Effect of homoharringtonine on the viability of murine leukemia P388 cells resistant to either adriamycin, vincristine, or 1-beta-D-arabinofuranosylcytosine.
    Wilkoff LJ, Dulmadge DA, Laster WR, Griswold DP.
    Cancer Chemother Pharmacol; 1989 May 15; 23(3):145-50. PubMed ID: 2924372
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of quinidine effect on the antitumor activity of adriamycin and mitoxantrone in adriamycin-sensitive and -resistant P388 leukemia cells.
    Parekh H, Chitnis M.
    Sel Cancer Ther; 1990 May 15; 6(2):93-102. PubMed ID: 2367755
    [Abstract] [Full Text] [Related]

  • 15. SDZ 280-446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein-mediated tumour cell multidrug resistance.
    Loor F, Boesch D, Gavériaux C, Jachez B, Pourtier-Manzanedo A, Emmer G.
    Br J Cancer; 1992 Jan 15; 65(1):11-8. PubMed ID: 1346365
    [Abstract] [Full Text] [Related]

  • 16. Enhancement of vincristine- and adriamycin-induced cytotoxicity by verapamil in P388 leukemia and its sublines resistant to vincristine and adriamycin.
    Tsuruo T, Iida H, Yamashiro M, Tsukagoshi S, Sakurai Y.
    Biochem Pharmacol; 1982 Oct 01; 31(19):3138-40. PubMed ID: 7150340
    [Abstract] [Full Text] [Related]

  • 17. New triazine derivatives as potent modulators of multidrug resistance.
    Dhainaut A, Régnier G, Atassi G, Pierré A, Léonce S, Kraus-Berthier L, Prost JF.
    J Med Chem; 1992 Jun 26; 35(13):2481-96. PubMed ID: 1352353
    [Abstract] [Full Text] [Related]

  • 18. Reversal of drug sensitivity in MDR subline of P388 leukemia by gene-targeted antisense oligonucleotide.
    Nakashima E, Matsushita R, Negishi H, Nomura M, Harada S, Yamamoto H, Miyamoto K, Ichimura F.
    J Pharm Sci; 1995 Oct 26; 84(10):1205-9. PubMed ID: 8801335
    [Abstract] [Full Text] [Related]

  • 19. Resistance to adriamycin: relationship of cytotoxicity to drug uptake and DNA single- and double-strand breakage in cloned cell lines of adriamycin-sensitive and -resistant P388 leukemia.
    Goldenberg GJ, Wang H, Blair GW.
    Cancer Res; 1986 Jun 26; 46(6):2978-83. PubMed ID: 3698020
    [Abstract] [Full Text] [Related]

  • 20. Reversal of multidrug resistance by novel nitrophenyl pyrones, SNF4435C and D.
    Kurosawa K, Takahashi K, Tsuda E, Tomida A, Tsuruo T.
    Jpn J Cancer Res; 2001 Nov 26; 92(11):1235-41. PubMed ID: 11714449
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.